Category: Finance News Network

  • Wallstreet-Billionaire.com AI-Powered Instant Feedback Trading App Reveals Why Retail Traders Lose

    ZURICH, Switzerland — Wallstreet-Billionaire.com is an AI trading simulator, designed to help traders become profitable, find their edge, avoid losing trades and focus on profitable patterns.

    Routine, practice and know-how are essential in trading. WallStreet-Billionaire.com analyzed thousands of demo trades done with the instant feedback free demo trading tool revealing retail traders main weaknesses.

    “Most retail traders fail because they try to force trading strategies that do not fit their personality or skills,” said a spokesperson for Wallstreet-Billionaire.com. “Trading is a highly competitive business and needs a lot of practice, routine and understanding of own intrinsic action patterns. Retail traders lack the routine and the knowledge of the own edge.». On WallStreet-Billionaire.com traders place dozens of trades in just minutes, get instant profit/loss results and get advice from an AI Coach. Additionally the trade replay videos help traders understand how they traded compared to the best possible way of trading this chart. The TradeVision AI can furthermore select real market underlyings where the chart match the traders profitable trade setups. Perfections needs practice.». 

    • Realistic Market Practice: Traders execute paper trades against 600.000 real charts  with instant profit and loss (P&L) feedback. The trade replay sheds light on the traders past actions and how to optimize the trades for higher profitability or avoidance of losses..
    • Trade Replay: The trade replay sheds light on the traders past actions and how to optimize the trades for higher profitability or avoidance of losses..
    • Personalized AI Trading Coach: An integrated AI mentor analyzes trade management, identifies costly mistakes, and suggestions for trade configurations.
    • Performance Analytics: Comprehensive statistics quantify the trader’s approach and extrapolate whether or not this trading style can be profitable over a longer period of time.
    • TradeVision AI: After completing 100 free simulated trades, the AI identifies the precise technical setups where the trader naturally excels and suggests matching charts in the real markets.

    The trading simulator is 100% free to start and accessible immediately in any browser without requiring downloads or credit cards.

    To test your skills and uncover your trading edge, visit https://wallstreet-billionaire.com.

    About Wallstreet-Billionaire.com

    Developed by inside finance GmbH in Switzerland, Wallstreet-Billionaire.com is an AI training platform for traders. By integrating realistic chart simulation, performance tracking, and AI-driven coaching, the platform empowers retail investors to discover their abilities, refine high-probability trading patterns, and find real market trades matching their profitable trade patterns.

    Media Contact:

    Press & Communications
    inside finance GmbH / Wallstreet-Billionaire.com
    Email: guenther@insidefinance.ch

  • Fully Permitted Tanzanian Gold Project Clears Path to Construction as Financing, EPCM Fall in Place (LVGLF)

    Dallas, United States, August 31st, 2026, FinanceWire

    Disseminated on behalf of Lake Victoria Gold

    As gold prices held near record levels through the first half of 2026, investor attention has increasingly turned to a key question in the mining sector: which developers are closest to transitioning from permitted deposits to producing mines. Lake Victoria Gold (TSXV: LVG) (OTCQB: LVGLF) (FSE: E1K) has cleared a sequence of milestones on its Imwelo project in Tanzania that position the company at that threshold. 

    Read more https://wallstreetpr.com/from-developer-to-producer-minings-biggest-valuation-shift/

    The Imwelo project holds Mining Licence ML 538/2015 and is fully permitted. A 23-hole, 1,136-metre sterilization drilling program completed in June confirmed that the plant and accommodation footprints are clear of mineralization. On June 29, 2026, the Tanzania Mining Commission approved a Tanzanian-led EPCM (Engineering, Procurement, and Construction Management) structure for the project, with City Engineering Company Ltd. serving as primary contractor and Sutton Consulting International providing international technical support; Senior Project Manager Charl Coetzee mobilized to site on July 8, 2026. On the financing side, the company entered into a binding term sheet on April 1, 2026 for a gold loan of up to 6,000 ounces, approximately US$25 million from Monetary Metals, to be repaid in gold ounces rather than cash, and closed the final tranche of a convertible debenture financing on July 2, 2026, bringing that raise to $4,165,200. Construction start is targeted for the current quarter.

    Markets have historically applied deep discounts to development-stage mining companies to reflect the execution risks associated with permitting, financing, construction, and commissioning. As those risks are retired, companies have often seen valuations shift from a developer’s discount toward a producer’s multiple. G Mining Ventures (TSX: GMIN) (OTCQX: GMINF) offers a recent example, having built the Tocantinzinho mine in Brazil on time and on budget, poured first gold in 2024, and produced 171,871 ounces generating approximately $580 million in revenue in its first full year of commercial production in 2025. Lundin Gold (TSX: LUG) (OTCQX: LUGDF) acquired the Fruta del Norte deposit in Ecuador for $240 million in 2014, reached commercial production in 2020, produced 498,315 ounces in 2025, and now carries a market value in the C$20 billion range. Montage Gold (TSX: MAU) (OTCQX: MAUTF) is undergoing the same transition, with its fully funded, $825 million Koné project in Côte d’Ivoire advancing ahead of schedule and first gold now targeted for the fourth quarter of 2026. TRX Gold (NYSE American: TRX) (TSX: TRX) is demonstrating the same trajectory within Tanzania itself: its Buckreef mine, located in the same Geita greenstone belt as Imwelo, produced 7,426 ounces last quarter at a record average realized price of $4,703 per ounce. Barrick holds an equity position in Lake Victoria Gold, Tanzania’s Taifa Group is contracted for civil works and contract mining, and management, directors, and strategic partners collectively hold more than 60% of shares outstanding.

    Imwelo has been the subject of JORC-code Preliminary Economic Assessment and pre-feasibility work; however, these studies are not current under NI 43-101, and the company has not completed a feasibility study establishing mineral reserves under CIM Definition Standards. Any decision to commence production is not based on a feasibility study of mineral reserves and carries an increased risk of economic or technical failure.

    Read more https://wallstreetpr.com/from-developer-to-producer-minings-biggest-valuation-shift/

    About Lake Victoria Gold

    Lake Victoria Gold is a rapidly growing gold exploration and development company listed on the TSX Venture Exchange under the symbol LVG. Leveraging our unique position and experience, the Company is principally focused on growth and consolidation in the highly prolific and prospective Lake Victoria Goldfield in Tanzania. The Company has a 100% interest in the Tembo project which has over fifty thousand meters of drilling and is located adjacent to Barrick’s Bulyanhulu Mine. The Company also holds a 100% interest in the Imwelo Project which is a fully permitted gold project west of AngloGold Ashanti’s Geita Gold Mine. With historical resource estimates and a JORC Compliant 2021 pre-feasibility study, the project is fully permitted for mine construction and production, positioning it as a near-term development opportunity. LVG has assembled a highly experienced team with a track record of developing, financing, and operating mining projects in Africa with management, directors and partners owning more than 60% of the shares. Notably, the Company is grateful for the validation that comes with the support and equity investment from Barrick and strategic partnership with Taifa Group. Taifa Group (a diverse group of companies with interests in amongst others, Mining, Telecoms, Oil & Gas, Agri Business, Pharmaceuticals and Leather) has entered into an agreement with the Company to obtain an equity stake in the Company and through its wholly owned subsidiary Taifa Mining (a wholly Tanzanian owned company), or other nominees. Taifa Mining will also conduct all the contract mining and civil works for the Imwelo project. Taifa Mining is Tanzania’s largest mining contractor with over 30 years mining related experience. Taifa have been the contractor of choice to most mines in Tanzania and have maintained long and successful relationships with companies such as Petra, De Beers, Barrick, and AngloGold Ashanti. In addition, Taifa also owns the largest fleet of mining equipment in Tanzania. As a company, Taifa is committed to adopting and adhering to the latest internationally recognized standards throughout all aspects of its business.

    Forward-Looking Statements

    This press release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws, including statements regarding the timing of construction, financing, and project development. Such statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially. Readers are cautioned not to place undue reliance on forward-looking statements.

    NOTE TO INVESTORS: WallStreetPR is a financial news and publishing company that maximizes investor awareness for public and private businesses. Its core mission is to empower individuals by creating a highly connected, well-informed investor community. For more information, please visit https://wallstreetpr.com. Please see full terms of use and disclaimers on the WallstreetPR website applicable to all content provided by WallstreetPR, wherever published or re-published: https://wallstreetpr.com/disclaimer/. Please note that Akchirpy Media LLP has been compensated two thousand dollars for distributing this content on behalf of EDM Media LLC.

    Sources: https://www.newsfilecorp.com/release/303579/Lake-Victoria-Gold-Formalizes-TanzanianLed-EPCM-Team-Advancing-the-Fully-Permitted-Imwelo-Gold-Project-Toward-Construction 

    https://www.newsfilecorp.com/release/304339/Lake-Victoria-Gold-Mobilizes-Senior-Project-Manager-to-Imwelo-as-Construction-Readiness-Advances 

    Corporate Communications

    WallstreetPR

    Dallas, Texas

    www.WallStreetPR.com

    214-506-0507 Office

    Info@WallStreetPR.com

    Contact

    CEO
    Stephen Sandifer
    WallStreetPR
    editor@wallstreetpr.com
    +1 (800) 301-7883

  • RedHill Divests Talicia® to Apotex for $18 Million Cash Upfront Plus Milestones to Fuel Strategic Growth Opportunities

    Raleigh, United States, August 31st, 2026, FinanceWire

    Executes a major step in RedHill’s strategic roadmap to fundamentally reposition the Company’s commercial business toward new and larger product opportunities, revenue growth and an accelerated path toward operational profitability

    —

    Realizes substantial value from RedHill’s 70% stake in Talicia, currently held within a shared ownership and economic structure, while immediately creating a stronger liquidity position and fully funding the next major steps in RedHill’s transformational commercial expansion

    —

    Under the terms of the agreement, Apotex will pay RedHill an upfront payment of $18 million plus up to an additional $35 million in potential worldwide net sales milestone payments

     

    RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced the divestment of its Talicia business to a subsidiary of Apotex Health Corp. (TSX: APTX) (“Apotex”) for an upfront payment of $18 million plus up to an additional $35 million in potential payments based on worldwide net sales milestones.

    “This transaction is a pivotal milestone for RedHill. We are converting our 70% stake in Talicia into immediate capital, significantly stronger liquidity and meaningful potential upside, while fully funding the next major step in our commercial business expansion. I want to thank the RedHill team for developing and positioning this important product for success, targeting H. pylori infection, the main cause of gastric cancer and stomach ulcers,” said Dror Ben-Asher, RedHill’s Chief Executive Officer. “We are confident that given its proven capabilities, Apotex is the right home to grow Talicia globally. We thank Apotex for their partnership on the successful conclusion of this transaction, which unlocks the resources needed to scale RedHill’s existing gastrointestinal (GI) commercial franchise into a stronger and larger one, including new, high-value, FDA-approved product opportunities intended to drive sustained growth and accelerate our path toward operational profitability.”

    Under the terms of the agreement, RedHill received $18 million in cash and has the potential to receive up to an additional $35 million in payments based on worldwide net sales milestones from Apotex. In return, Apotex will receive RedHill’s 70% interest in Talicia, following Apotex’s prior acquisition of Cumberland Pharmaceuticals Inc.’s U.S. branded business, which included Cumberland Pharmaceuticals Inc.’s 30% ownership in Talicia.

    RedHill was advised by Morningstar Law Group and Greenberg Traurig LLP on this transaction.

    About RedHill Biopharma  

    RedHill Biopharma Ltd. (Nasdaq: RDHL) is a specialty biopharmaceutical company primarily focused on U.S. development and commercialization of drugs for gastrointestinal diseases, infectious diseases and oncology. RedHill’s key clinical late-stage development programs include: (i) opaganib (ABC294640), a first-in-class, orally administered sphingosine kinase-2 (SPHK2) selective inhibitor with anti-inflammatory, antiviral, metabolic and anticancer activity, targeting multiple indications with a track record of U.S. government and academic collaborations intended for medical countermeasure development including for EVD, radiation exposure indications such as GI-Acute Radiation Syndrome (GI-ARS), an ongoing Phase 2 study in prostate cancer in combination with darolutamide and a Phase 2/3 program for hospitalized COVID-19; (ii) RHB-102 (Bekinda), with a planned Phase 2 proof-of-concept study for GLP-1/GIP receptor agonist-associated GI intolerance, positive results from a U.S. Phase 3 study for acute gastroenteritis and gastritis, positive results from a U.S. Phase 2 study for IBS-D and potential UK submission for chemotherapy and radiotherapy induced nausea and vomiting. RHB-102 is partnered with Hyloris Pharmaceuticals (EBR: HYL) for worldwide development and commercialization outside North America; (iii) RHB-204, a next-generation optimized formulation of RHB-104, with a planned Phase 2 study for Crohn’s disease (based on RHB-104’s positive Phase 3 Crohn’s disease study results); and (iv) RHB-107 (upamostat), an oral broad-acting, host-directed, serine protease inhibitor with potential for pandemic preparedness, including COVID-19 and also targeting multiple cancer and inflammatory gastrointestinal diseases.

    About Apotex 

    Apotex is a Canadian-based global health company. Apotex improves everyday access to affordable, innovative medicines and health products for millions of people around the world, with a broad portfolio of generic, biosimilar, and innovative branded pharmaceuticals, and consumer health products. Headquartered in Toronto, with regional offices globally, including in the United States, Mexico, and India, Apotex is the largest Canadian-based pharmaceutical company and a health partner of choice for the Americas for pharmaceutical licensing and product acquisitions.

    Forward Looking Statements

    This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and may discuss investment opportunities, stock analysis, financial performance, investor relations, and market trends. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words, and include, among others, statements regarding the divestment of Talicia and the potential use of the proceeds of that sale; the Company’s ability to acquire or develop new products, expected revenue growth, the Company’s anticipated path toward operational profitability, and the Company’s strategic plans for its commercial business. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified, and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation: the risk that the divestment of Talicia does not result in any planned asset acquisitions, or that any such acquisitions are not commercially successful; the risk that proceeds from the transaction are insufficient to fund the Company’s strategic plans or that such plans do not achieve the anticipated results; the risk that opaganib is not accepted into Ebola virus disease control programs, or if accepted, that it does not demonstrate efficacy; the risk that development of RHB-204 for Crohn’s disease may not be completed, or if completed may not be approved or may not achieve commercial success; the risk that opaganib is not effective against the indications for which we develop our products; the risk that RHB-102 (Bekinda) does not effectively reduce GLP-1/GIP-related nausea, vomiting and diarrhea; the risk regarding the Company’s ability to regain and maintain compliance with Nasdaq’s listing requirements, including the minimum bid price requirement; the risk that the addition of new revenue generating products or out-licensing transactions will not occur; the risk that the Company will not receive future milestone payments under its existing agreements, including under the Apotex agreement, or that they will be less than anticipated; the risk of current uncertainty regarding U.S. government research and development funding and that the U.S. government is under no obligation to continue to support development of our products and can cease such support at any time; the risk that acceptance onto the RNCP Product Development Pipeline or other governmental and non-governmental development programs will not guarantee ongoing development or that any such development will not be completed or successful; the risk that the FDA does not agree with the Company’s proposed development plans for its programs; the risk that the Company’s development programs and studies may not be successful and, even if successful, such studies and results may not be sufficient for regulatory applications, including emergency use or marketing applications, and that additional studies may be required; the risk that the Company will not successfully commercialize its products; as well as risks and uncertainties associated with (i) the initiation, timing, progress and results of the Company’s research, manufacturing, pre-clinical studies, clinical trials, and other therapeutic candidate development efforts, and the timing of the commercial launch of its commercial products and ones it may acquire or develop in the future; (ii) the Company’s ability to advance its therapeutic candidates into clinical trials or to successfully complete its pre-clinical studies or clinical trials or the development of any necessary commercial companion diagnostics; (iii) the extent and number and type of additional studies that the Company may be required to conduct and the Company’s receipt of regulatory approvals for its therapeutic candidates, and the timing of other regulatory filings, approvals and feedback; (iv) the manufacturing, clinical development, commercialization, and market acceptance of the Company’s therapeutic candidates; (v) the Company’s ability to establish and maintain corporate collaborations; (vi) the Company’s ability to acquire products approved for marketing in the U.S. that achieve commercial success and build its own marketing and commercialization capabilities; (vii) the interpretation of the properties and characteristics of the Company’s therapeutic candidates and the results obtained with its therapeutic candidates in research, pre-clinical studies or clinical trials; (viii) the implementation of the Company’s business model, strategic plans for its business and therapeutic candidates; (ix) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its therapeutic candidates and its ability to operate its business without infringing the intellectual property rights of others; (x) parties from whom the Company licenses its intellectual property defaulting in their obligations to the Company; (xi) the Company’s ability to collect on its judgement against Kukbo; (xii) estimates of the Company’s expenses, future revenues, capital requirements and needs for additional financing; (xiii) the effect of patients suffering adverse experiences using investigative drugs under the Company’s Expanded Access Program; (xiv) competition from other companies and technologies within the Company’s industry; and (xv) the hiring and employment commencement date of executive managers. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 20-F filed with the SEC on April 27, 2026. All forward-looking statements included in this press release are made only as of the date of this press release. The Company assumes no obligation to update any written or oral forward-looking statement, whether as a result of new information, future events or otherwise unless required by law.

    Contact

    Chief Corporate & BD Officer
    Adi Frish
    RedHill Biopharma
    adi@redhillbio.com

  • EdWealth Announces MoneyBench Benchmark Comparing AI Money Answers From Ed, ChatGPT and Gemini

    New York, United States, August 31st, 2026, FinanceWire

    EdWealth (edwealth.ai) today announced the publication of MoneyBench, a benchmark developed by the company to evaluate how AI systems answer personal finance questions. The benchmark compares Ed, EdWealth’s AI personal finance coach, with ChatGPT and Gemini on usefulness and factual accuracy.

    Ask an AI about money and a confident, plausible answer arrives instantly. Whether the numbers are right is invisible as you read. In an Intuit Credit Karma survey, 52% of adults who acted on AI financial advice reported a poor decision [1].

    According to EdWealth’s MoneyBench results for July, Ed ranked first, winning 62.3% of questions, compared with 20.8% for Gemini and 17.0% for ChatGPT [2].

    What made the difference

    Writing quality did not separate the three, and accuracy scores often matched. Usefulness did: Ed averaged 4.24 on a five-point scale to ChatGPT’s 3.62 and Gemini’s 3.47, higher on roughly seven of ten questions against each.

    Five things set Ed apart:

    • Live numbers. Ed’s 120-plus financial data-and-analysis tools query the current filing, live price, holdings table, not last quarter’s memory.
    • Decision-first answers. Conclusion first, then reasoning, then options.
    • Fact and interpretation, separated. Limits and deadlines are stated as rules, context and trade-offs as interpretation. Most AI blurs the two.
    • A coach that stays. From what a user shares, Ed learns their numbers, goals and habits; every answer builds on the last, across cash flow, taxes, stock compensation, funds, insurance. Account connections are read-only.
    • Statute, not guesswork. Phase-outs, benefit formulas and multi-year tax rules come from a base of 11,566 parameters, sourced to the IRS, SSA, CMS and state authorities, across 51 US jurisdictions.

    Confidence is not correctness

    “Wealthy families always had a money person to call. Everyone else got search results, then a confident chatbot,” said Allen Ng, founder of EdWealth. “Ed closes that gap: live numbers, the reasoning shown, the decision still yours.”

    The answers were scored by Claude, an AI from Anthropic, which builds none of the three. It checked each answer’s key figures against live sources, and an answer containing a fact proven false could not win. That check cost Ed: its score fell 5.3 points, both competitors rose, and Ed still finished first. Its 40 losses appear in the paper beside the wins. Where Ed’s facts were wrong, its usefulness fell with them: useful answers are built on correct ones.

    In May’s first round Ed placed third of three, held back by weak data retrieval. EdWealth rebuilt it, and Ed has led every round since.

    The part no benchmark can measure

    The same question has a different right answer for each person: holdings, taxes, goals. A general assistant answers for everyone; Ed answers for one person, and keeps learning them. The test could not see that: standalone questions, nothing known about the asker. A benchmark measures the answer; a money person of your own knows the question behind it.

    The full paper, with complete results, method and limitations: edwealth.ai/moneybench.

    “We put our product on trial in public,” said Ng. “Financial AI should be judged on one question: does it help a person make a better money decision. Useful, and right. Only then does the rest follow. Money at peace, wealth in motion.”

    About EdWealth

    EdWealth builds agentic AI products for personal financial clarity and Financial Fitness. Its debut product, Ed, is a personal finance coach for modern households; user data is never for sale. Ed is available at edwealth.ai, on the App Store, and on Google Play.

    Disclaimer: Ed provides financial information and education only — not investment, tax, or legal advice, and not a recommendation to buy or sell anything. Ed does not provide personalised investment recommendations. Ed is not a licensed financial adviser; its AI-generated outputs may be wrong, and all decisions are your own. Consult a licensed professional before acting. Availability, features, and pricing may vary by jurisdiction; Ed is offered only where permitted by applicable law.

    Website: https://www.edwealth.ai/

    Instagram: https://www.instagram.com/edwealth.ai/

    Media contact: info@edwealth.ai

    Sources: [1] Intuit Credit Karma, survey of 1,019 US adults, fielded August 7-14, 2025. [2] Systems as tested, July 2026: Ed in production configuration; ChatGPT (GPT-5.6 Sol) at Pro effort; Gemini (3.6 Flash) at default configuration.

    Contact

    Communications Lead
    Phoebe Woo
    EdWealth
    info@edwealth.ai

  • MEXC Data: BTC Breaks $80,000, Major-Asset Spot Trading Volume Surges 300%

    Mutsamudu, Comoros, August 31st, 2026, Chainwire

    MEXC, a pioneer in 0-fee digital asset trading, reports a sharp rise in Spot trading activity on the platform as BTC topped $80,000 and ETH and SOL reached near six-month highs. From August 20 to 22, the average daily Spot trading volume of BTC, ETH, SOL, and XRP increased by approximately 299% from the daily average recorded between August 1 and 17. Over the same period, the combined average daily trading volume of ETH, SOL, and XRP exceeded that of BTC. Compared with the BTC-dominated trading structure seen from August 1 to 17, activity on the platform spread noticeably across a broader range of major assets.

    This shift in trading composition had already emerged on August 19. On that day, the combined trading share of ETH, SOL, and XRP rose from 30.5% a day earlier to 46.7%, an increase of 16.2 percentage points and the largest single-day gain in August. Their combined daily share subsequently remained above the 34.9% baseline recorded from August 1 to 17, indicating that trading interest in these three major assets had begun to rise before BTC broke above $80,000.

    On August 25, when BTC topped $80,000, BTC Spot trading volume increased by approximately 164% from the August 1 to 17 daily average. ETH volume rose by 220%, while SOL and XRP each increased by approximately 500%. BTC remained an important market signal during this rally, but the increase in platform activity was not limited to BTC. Instead, multiple major assets became active at the same time.

    The trend continued on August 27, when ETH and SOL climbed to nearly six-month highs. On MEXC, ETH Spot trading volume increased by 36.3% from the previous day, while SOL volume rose by 109.7%. Together, the two assets accounted for 46.4% of combined trading volume across the four assets, marking a new August high and making them the primary drivers of the day’s increase in trading activity.

    As market sentiment strengthens, trading demand can rotate quickly across major assets, making trading costs and execution efficiency increasingly important for users seeking to respond to market movements. MEXC currently offers 0-fee trading on selected SOL Spot trading pairs and all XRP Spot trading pairs. Combined with deep liquidity, this enables users to navigate market rotations at lower cost and with greater efficiency while capturing more opportunities.

    About MEXC

    MEXC is the world’s fastest-growing cryptocurrency exchange, trusted by more than 40 million users across 170+ markets. Built on a user-first philosophy, MEXC offers industry-leading 0-fee trading and access to over 3,000 digital assets. As the Gateway to Infinite Opportunities, MEXC provides a single platform where users can easily trade cryptocurrencies alongside tokenized assets, including stocks, ETFs, commodities, and precious metals.

    MEXC Official Website| X | Telegram |How to Sign Up on MEXC

    For media inquiries, please contact MEXC PR team: media@mexc.com

    Contact

    MEXC PR team
    media@mexc.com

  • DeXenY Expands Its Decentralized Energy Vision to a Wider Web3 Audience as $DXY Prepares for Bitvoux Launch 

    The upcoming Bitvoux launch will expand access to $DXY, the utility token connecting DeXenY’s blockchain, distributed energy, RWA, and AI infrastructure.

    Road Town, British Virgin Islands, August 30, 2026, DeXenY is preparing to bring its native utility token, $DXY, to Bitvoux, expanding access to a token designed around one of Web3’s increasingly important real-world applications: connecting decentralized infrastructure with measurable physical activity.

    The upcoming launch introduces $DXY to a broader digital-asset audience while DeXenY develops a decentralized energy protocol connecting rooftop solar, battery storage, electric vehicles and microgrids through blockchain-based settlement, verifiable energy data and AI-enabled coordination.

    Unlike a token designed primarily around digital activity, $DXY is being developed around participation in a physical energy network.

    Its utility spans four core areas: energy settlement, rewards for verified clean-energy generation, network staking and governance.

    Why Energy Is Moving Toward Decentralized Infrastructure

    Electricity systems are becoming increasingly distributed.

    Homes can generate electricity through rooftop solar. Batteries can store energy and release it when needed. Electric vehicles are emerging as mobile energy assets, while microgrids allow communities and businesses to manage electricity at a more localized level.

    This shift creates a new challenge: coordinating large numbers of independently owned energy resources while establishing trusted records of what was generated, stored, consumed, and exchanged.

    DeXenY is building its protocol around this coordination problem.

    Smart meters and connected infrastructure provide the physical data layer. Oracle infrastructure is designed to verify and corroborate that information. Blockchain provides programmable settlement and an auditable transaction layer, while AI can help coordinate decisions across participating energy resources.

    The result is a model designed to move from physical activity to verifiable digital settlement: Energy activity → Data verification → Programmable settlement

    $DXY Connects the Network’s Economic Functions

    Within this architecture, $DXY acts as the common utility layer connecting participants and protocol functions.

    The token is designed to facilitate peer-to-peer energy settlement and support DeXenY’s Proof-of-Generation mechanism, through which rewards correspond with verified clean-energy generation.

    $DXY is also designed to be staked by validators and oracle participants involved in data verification and to support participation in the protocol’s multi-stakeholder governance model.

    This creates a direct connection between token utility and the activities DeXenY is designed to coordinate across its energy ecosystem.

    Where Energy, RWA and AI Converge

    DeXenY’s architecture extends beyond energy transactions.

    The protocol is designed to connect physical infrastructure and energy-related economic activity with real-world asset infrastructure, including physical energy assets, energy-derived cash flows and environmental commodities.

    AI forms another layer of the model.

    DeXenY envisions AI agents supporting decisions across distributed resources using variables such as electricity prices, weather conditions, demand and grid signals. AI-assisted verification can also contribute to identifying anomalies and strengthening the integrity of energy data before it is connected with blockchain infrastructure.

    This creates a convergence of technologies that have often developed independently:

    Energy × Web3 × RWA × AI

    For DeXenY, the objective is to bring those layers together around a common source of real-world activity: energy.

    Bitvoux Launch Expands Access to $DXY

    The upcoming Bitvoux launch is designed to make $DXY accessible to a broader digital-asset audience as DeXenY builds out its decentralized energy ecosystem.

    It also gives Web3 participants another way to discover a project applying blockchain and token infrastructure beyond purely digital markets.

    “The transition to distributed energy creates millions of new participants and connected assets across the electricity system. DeXenY is designed to provide the trust, settlement and intelligence infrastructure connecting that activity, with $DXY serving as the utility layer across the network.”

    Additional information regarding the $DXY launch on Bitvoux and trading availability will be communicated through DeXenY’s official channels.

    About DeXenY

    DeXenY (pronounced “dee-Zen-i”) is a decentralized energy protocol designed to serve as a trust, settlement, and intelligence layer for the distributed energy economy. The protocol brings together distributed energy resources, blockchain-based settlement, tokenized real-world assets, and AI-enabled coordination.

    Its native utility token, $DXY, is designed to support energy settlement, Proof-of-Generation rewards, network staking, and multi-stakeholder governance across the DeXenY ecosystem.

    Website: https://dexeny.co/
    Whitepaper: https://dexeny.co/whitepaper
    Telegram: https://t.me/dexeny_official
    X: https://x.com/dexeny_off 

  • Why Full-Mouth Rehabilitation Requires More Than Replacing Missing Teeth

    • Dr. Irfan Atcha says complex dental rehabilitation depends on careful planning, function, healing, and long-term stability.

    Illinois, USA, Aug 30, 2026, ZEX PR WIRE — Replacing missing teeth is only one part of full-mouth rehabilitation, according to Chicago implant dentist Dr. Irfan Atcha.

    For patients with several missing, failing, or damaged teeth, the greater challenge is understanding how the entire mouth functions as a single system. That means looking beyond individual teeth and considering factors such as bite, bone support, healing, comfort, and long-term stability.

    Atcha has spent nearly three decades working with patients who need complex dental rehabilitation. Since beginning his career in Chicago in 1996, his work has increasingly focused on dental implants, full-arch treatment, implant-supported dentures, and cases that require more detailed planning.

    “When you are dealing with a complex case, replacing the missing teeth is only part of the picture,” Atcha said. “You have to think about how everything works together and what the patient will need over the long term.”

    Full-Mouth Rehabilitation Starts With the Bigger Picture

    A patient may first seek treatment for an obvious concern, such as missing teeth or difficulty chewing. But in more advanced cases, the underlying issues may involve several areas at once.

    That is why Atcha believes full-mouth rehabilitation should begin with a broader evaluation.

    “You cannot always treat one problem in isolation,” he said. “The bite, the bone, the remaining teeth, and the way the mouth functions all influence the final plan.”

    That approach has become a central part of his work in implant dentistry.

    His areas of focus include same-day dental implants, implant-supported dentures, All-on-4 dental implants, and full-arch rehabilitation. These treatments can involve several clinical decisions that need to work together rather than being addressed separately.

    Why Planning Matters Before Treatment Begins

    For Atcha, one of the most important parts of complex dental care happens before treatment starts.

    A full rehabilitation plan may need to account for the condition of existing teeth, the amount of available bone, the patient’s bite, and how the final restoration is expected to function.

    “Good planning means thinking several steps ahead,” Atcha said. “You are not only asking what can be done today. You are asking how that decision may affect the overall result later.”

    That long-term mindset has shaped his approach throughout his career.

    Atcha often points to “long-term success with dental implants” as one of the key themes in his work. In his view, a treatment should not be judged only by what happens on the day of the procedure.

    The larger question is how well the rehabilitation continues to function over time.

    Complex Cases Require More Than One Solution

    Full-mouth rehabilitation is not a single treatment. Different patients may have very different needs, even when their dental problems appear similar at first.

    One person may need several teeth replaced. Another may require a full-arch solution. Others may need a combination of treatments to rebuild function across the mouth.

    That is why Atcha sees experience and clinical judgement as important parts of the process.

    “Two patients can come in with what looks like the same problem and still need very different treatment plans,” he said. “You have to understand the individual case rather than trying to force every patient into the same approach.”

    That principle has guided much of his work with complex implant patients in the Chicago area.

    Nearly 30 Years of Changing Treatment Options

    Atcha began practising in 1996 after earning his Doctor of Dental Surgery degree from the University of Illinois College of Dentistry.

    He had previously earned a Bachelor of Science in Biochemistry from the University of Illinois in 1991, and his early interest in research continued during dental school, where he received first-place recognition for a biochemistry table clinic presentation.

    Over the decades since, implant dentistry has continued to evolve. Advances in imaging, treatment planning, materials, and clinical techniques have created more options for patients with advanced dental needs.

    Atcha has continued his education alongside those changes, earning Fellowship and Diplomate recognition through both the International Congress of Oral Implantologists and the International Dental Implant Association.

    He says new technology can improve treatment planning, but it does not remove the need for careful evaluation.

    “Technology gives us more information, but the information still has to be interpreted,” he said. “The goal is to use those tools as part of a complete plan.”

    Looking Beyond Missing Teeth

    For patients considering full-mouth rehabilitation, Atcha believes the most important conversation is often about the larger goal. Replacing missing teeth may be the most visible part of treatment, but restoring function requires looking at how the whole system works together.

    That means considering not only what is missing, but also what remains, how the patient bites, how healing may occur, and how the final result is expected to perform over time.

    For Atcha, that broader perspective is what separates simple tooth replacement from full-mouth rehabilitation.

    “The goal is not just to fill a space,” he said. “The goal is to create a treatment plan that makes sense for the whole mouth and for the patient’s long-term needs.”

    For more information about Dr. Irfan Atcha and New Teeth Chicago, visit newteethchicago.com.

    About Dr. Irfan Atcha
    Dr. Irfan Atcha is a Chicago-based implant dentist who has been practising since 1996. He earned a Bachelor of Science in Biochemistry from the University of Illinois and a Doctor of Dental Surgery degree from the University of Illinois College of Dentistry. His work focuses on dental implants, full-arch rehabilitation, same-day dental implants, implant-supported dentures, and complex treatment planning.

  • Clayton Fields Identifies Questions to Ask Before Replacing Proven Technology

    • Woodstock, Georgia technology and go-to-market professional Clayton Fields explains why evaluating a new system should include the cost and complexity of leaving the old one behind.

    WOODSTOCK, Ga. Aug 30, 2026, ZEX PR WIRE — Businesses have more technology choices than ever, but Clayton Fields believes the availability of a newer system does not automatically make replacing an existing one the right decision.

    Fields, a Woodstock, Georgia-based go-to-market professional with decades of experience in enterprise technology, security software, services, startups, and AI-enabled solutions, has spent much of his career working around organizations evaluating new technology. He says those decisions can become too focused on the capabilities of the new product while overlooking an equally important question: What will it actually take to replace what is already working?

    “When companies evaluate new technology, the conversation naturally starts with what the new product can do,” Fields said. “I think you also have to understand everything that has been built around the system you already have. Replacing technology is rarely just replacing technology.”

    What Problem Is the Business Actually Trying to Solve?

    Fields recommends beginning any replacement decision by clearly identifying the problem.

    A company may have an older system, but age alone does not necessarily make that system ineffective. The more important question is whether it is preventing the organization from accomplishing something important.

    Employees may be spending too much time on manual processes. Customers may be experiencing unnecessary delays. Security requirements may have changed. An existing system may no longer integrate effectively with other tools.

    Those are specific problems that can be evaluated.

    “If the main argument for replacing something is that a newer option exists, I would want to understand more,” Fields said. “What becomes meaningfully better after the change? That answer should be clear before the organization takes on everything involved in making the switch.”

    What Will Migration Really Require?

    Moving from one system to another can involve considerably more than purchasing new software.

    Organizations may need to migrate years of information, rebuild integrations, test workflows, update internal processes, and determine how the new system will interact with other technology.

    Fields says these requirements should be considered during the buying process rather than after a contract is signed.

    A new platform can offer significant advantages and still create a difficult transition. Understanding that transition helps businesses compare the potential benefits with the actual work required to achieve them.

    “The purchase is one decision, but implementation is where the organization has to live with that decision,” Fields said. “I want to know who owns the transition, what other systems are affected, and what happens if the migration takes longer than expected.”

    How Much Training and Behavior Change Will Be Needed?

    Technology adoption also depends on people.

    Employees may have spent years working with an existing system. They know its strengths, its weaknesses, and often the workarounds required to get their jobs done. A replacement can eliminate those limitations while simultaneously requiring employees to learn an entirely different way of working.

    Fields believes businesses should consider that learning curve when evaluating potential improvements.

    The question is not only whether the new technology is easier or more capable. Businesses should also consider how quickly employees can become comfortable with it and what support will be necessary during the transition.

    “You can have a better system and still have a difficult implementation if people do not understand how it fits into their work,” Fields said. “Adoption does not happen simply because the technology has been installed.”

    What Does the Existing System Already Do Well?

    Fields also encourages companies to make an honest assessment of the technology they are considering replacing.

    Older systems can become inefficient or restrictive, but established technology has advantages that are easy to ignore. Employees understand it. Processes have been designed around it. Integrations have already been established. The organization knows how the system behaves under normal and unusual conditions.

    That familiarity has value.

    Fields does not believe that means companies should remain with outdated technology indefinitely. Instead, he argues that the advantages of a replacement should be significant enough to justify giving up the stability the organization already has.

    “Proven technology can be boring, and sometimes boring is useful,” Fields said. “If something works every day and supports the business reliably, that should be part of the evaluation. You need a reason to introduce disruption.”

    What Happens If the Business Waits?

    The cost of changing technology deserves attention, but so does the cost of waiting.

    An organization can become overly comfortable with an existing system. Employees may gradually build manual workarounds around its limitations. Maintenance costs can rise. Security concerns can increase. A system that once supported the business may eventually prevent it from improving.

    Fields says this is why the decision should not be framed as simply choosing between new and old technology.

    Instead, businesses can ask what is likely to happen under both scenarios.

    “If we replace the system, what do we gain and what disruption do we create?” Fields said. “If we keep it for another year or two, what problems are likely to become more expensive or difficult? I think both sides of that question matter.”

    Is the Improvement Worth the Disruption?

    After years working with enterprise technology and newer solutions, Fields says he has become more deliberate about separating innovation from improvement.

    New capabilities can create real opportunities. Artificial intelligence, automation, security technologies, and other emerging tools are changing what organizations can accomplish. However, adopting those technologies still requires a practical business case.

    For Fields, the objective is not to keep every system forever or to adopt every new platform quickly. It is to understand when the improvement is substantial enough to make change worthwhile.

    “The goal should not be to have the newest technology,” Fields said. “The goal should be to have technology that supports what the business is trying to accomplish. Sometimes that means changing. Sometimes it means recognizing that what you already have is still doing its job.”

    About Clayton Fields

    Clayton Fields is a go-to-market professional based in Woodstock, Georgia, with extensive experience in enterprise technology. He spent nearly 10 years with a major technology company working across commercial sales, client services, infrastructure, storage, and business applications. For more than 13 years, he has worked with security software and services startups, including approximately a decade helping bring AI-enabled solutions to market.

    Fields holds a Bachelor of Science in Business Administration with honors. His professional interests include technology, entrepreneurship, artificial intelligence, customer adoption, and go-to-market strategy. Outside of work, he enjoys real estate remodeling, construction, hiking, and traveling, and he has volunteered with Habitat for Humanity.

    Media Contact

    Company Name:-Clayton Fields
    Company Website:-https://www.clayton-fields.com/

  • Flora Dong Discusses the Role of Human Judgment as AI Enters Wealth Management

    • Following Stanford’s AI Executive Education Program, the Founder and Managing Partner of Ardenwood Advisors shares observations on evaluating artificial intelligence while maintaining appropriate human oversight, privacy, security, and professional judgment.

    PALO ALTO, Calif., Aug 30, 2026, ZEX PR WIRE — As artificial intelligence becomes increasingly prominent across financial services, advisory firms are considering how the technology may fit within existing workflows while addressing questions involving oversight, information security, privacy, accuracy, and professional responsibility.

    For Flora Dong, Founder and Managing Partner of Ardenwood Advisors, those questions became a particular focus after attending the three-day AI Executive Education Program at Stanford. One concept she found especially relevant to wealth management was the distinction between using technology to automate human work and using it to augment human capabilities.

    “AI has introduced capabilities that are worth understanding, but I do not think the conversation should begin with how much work a technology can automate,” Dong said. “For me, the more useful starting point is understanding the problem a firm is trying to address and determining what level of human involvement remains appropriate.”

    Dong believes that distinction is particularly relevant for registered investment advisers because evaluating new technologies may involve considerations beyond efficiency. Depending on the application and how it is used, firms may need to consider their own policies and procedures, regulatory obligations, information-security practices, privacy considerations, recordkeeping requirements, supervisory processes, and methods for reviewing technology-generated information.

    “Being able to perform a task more quickly is different from determining whether a particular use of technology is appropriate,” Dong said. “Firms have to consider the information involved, how an output will be reviewed, and who remains responsible for the work.”

    Rather than viewing artificial intelligence as a single category of technology with a uniform role, Dong believes individual applications should be evaluated based on their purpose and circumstances.

    AI tools may assist with activities such as organizing information, supporting preliminary research, or performing certain administrative functions. However, the capabilities, limitations, security characteristics, and appropriate uses of individual systems can differ considerably.

    That makes human review an important part of the discussion, according to Dong.

    “An AI system may produce information quickly, but speed does not eliminate the need to evaluate that information,” she said. “The appropriate level of review will depend on the particular application, the information involved, and the way the technology is being used.”

    Dong also points to privacy and information security as considerations when financial services firms evaluate AI. Advisory firms may work with confidential or sensitive information, and introducing third-party technology can raise questions about how information is accessed, processed, retained, and protected.

    For that reason, Dong does not believe firms should assume that a technology appropriate for one workflow will necessarily be appropriate for another.

    “There is understandable excitement around AI, and I share that interest,” she said. “At the same time, I think firms need to understand the technology they are evaluating and consider how its use fits within their existing responsibilities, policies, and controls.”

    The Stanford program also prompted Dong to think more carefully about what happens when technology assists with tasks that have traditionally required significant employee time. While increased efficiency is frequently discussed as a potential benefit of AI, Dong believes firms still have to decide how any resulting capacity would be used.

    She cautions against assuming that additional technological capability necessarily translates into a particular business or client outcome.

    “Efficiency can be useful, but it is only one consideration,” Dong said. “If a process changes, I think it is important to understand what has actually changed and how the firm will evaluate whether the new process is appropriate for its intended purpose.”

    That perspective reflects Dong’s broader view that AI should be evaluated as a tool rather than as a substitute for professional responsibility.

    In wealth management, professionals regularly encounter circumstances in which information must be considered within the context of an individual client’s objectives, needs, and circumstances. Dong believes technology may assist with portions of that work without eliminating the need for people to evaluate information and exercise appropriate professional judgment.

    “The more capable these technologies become, the more important it may be to clearly define where the technology is assisting and where the person remains responsible,” Dong said. “I do not see exploring AI and maintaining human judgment as competing ideas. The challenge is determining how they can appropriately coexist.”

    Dong expects artificial intelligence to continue evolving, making it difficult to predict precisely how the technology will ultimately affect wealth management. Rather than making broad predictions about automation or the future of the advisor’s role, she believes firms can benefit from approaching individual applications deliberately and evaluating them within their own circumstances.

    “We are still learning what these technologies can and cannot do,” Dong said. “For me, that makes thoughtful evaluation more important. The question is not simply whether AI can perform a task. It is why we are using it, what risks and limitations need to be considered, how its work will be reviewed, and where human judgment remains necessary.”

    As AI capabilities continue to develop, Dong expects those questions to remain part of the broader conversation about technology in financial services.

    About Flora Dong

    Flora Dong is the Founder and Managing Partner of Ardenwood Advisors, an independent registered investment advisory firm based in Palo Alto, California. With more than 25 years of experience in wealth management, she works with individuals, families, entrepreneurs, and business owners, including many with financial interests across multiple countries. Her work may include investment advisory services, wealth planning, family office support, and coordination with clients’ other professional advisors, depending on each client’s circumstances.

    Dong has been recognized by Forbes among America’s Top Wealth Advisors, Top Women Advisors, and Best-In-State Wealth Advisors. Any third-party rankings or recognitions should be considered in accordance with the methodology, eligibility criteria, and time period applicable to the particular recognition and are not indicative of future performance or client experience.

    Important Disclosure

    This commentary reflects the personal opinions, viewpoints and analyses of the Arden Global Family Offices employees providing such comments, and should not be regarded as a description of advisory services provided by Arden Global Family Offices or performance returns of any Arden Global Family Offices client. The views reflected in the commentary are subject to change at any time without notice. Nothing in this commentary constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Any mention of a particular security and related performance data is not a recommendation to buy or sell that security. Arden Global Family Offices manages its clients’ accounts using a variety of investment techniques and strategies, which are not necessarily discussed in the commentary. Investments in securities involve the risk of loss. Past performance is no guarantee of future results.

    No advice may be rendered by Arden Global Family Offices unless a client service agreement is in place.

  • Post Oak Group Weighs In on Private Credit’s Expanding Role in Middle-Market Financing

    Post Oak Group, recognized as the top middle-market investment bank in Texas, weighs in on what private credit’s expanding role means for middle-market financing.

    Houston, Texas, United States, 29th Aug 2026 – As traditional bank lending has grown more selective, private credit has moved from the margins of the financial system to become a core source of capital for middle-market companies. According to PwC’s 2026 Global Private Credit Survey, the asset class now manages more than $2 trillion globally and is projected to reach $3.4 trillion by 2030, underscoring its growing importance in how businesses finance growth, acquisitions, and recapitalizations. Post Oak Group, recognized as the top middle-market investment bank in Texas, is highlighting what this shift means for business owners evaluating their financing options.

    “Private credit isn’t a niche alternative anymore; it’s become a mainstream financing tool that middle-market companies need to understand,” said David Chua, co-founder and Managing Partner at Post Oak Group. “As banks have pulled back from certain types of lending, private credit lenders have stepped in with more flexible, bespoke structures. For business owners, that means more paths to capital, but also more complexity in figuring out which path fits their situation, which is exactly where the right advisory relationship matters most.”

    A Broader Set of Financing Options

    Private credit’s growth has been driven by several converging factors: banks retrenching from certain lending categories, borrowers increasingly seeking customized structured solutions rather than standardized bank products, and investors’ ongoing search for yield in a higher-for-longer interest rate environment. What began as primarily direct corporate lending has since expanded into asset-backed finance, infrastructure debt, real estate debt, distressed debt, and specialty finance, giving companies liquidity solutions across a much wider range of risk profiles than were available even a few years ago.

    For middle-market business owners, this expansion translates into real optionality. Growth capital, acquisition funding, debt refinancing, and recapitalizations that might once have required a straightforward bank term loan can now be structured through private credit relationships that offer more flexibility on terms, timelines, and structure, often without requiring owners to give up operational control or dilute ownership the way an equity raise would.

    The PwC survey also found that sentiment among private credit portfolio managers remains strongly positive: more than 80% expect to receive increased capital allocations over the next 12 months, with nearly half anticipating growth of more than 20%. That continued inflow of capital into the asset class means middle-market companies are likely to see private credit remain a readily available, and increasingly competitive, financing option going forward.

    Access Is the Differentiator

    “The businesses that benefit most from this shift are the ones that work with advisors who actually have relationships across the private credit landscape, not just a list of lenders,” said Sunny Basra, Executive Director of Post Oak Group’s Capital Markets practice. “As one of the most connected firms to family offices and venture capital firms globally, we’re able to bring clients directly to the capital sources that fit their situation, rather than running a generic process and hoping something sticks.”

    Post Oak Group‘s Private Credit Advisory practice works with middle-market companies and investment funds to identify, structure, and secure capital from institutional sources, including private credit lenders, private equity firms, family offices, and strategic investors. That network, spanning family offices and venture capital relationships across North America, Europe, Asia, and the Middle East, combined with the firm’s standing as Texas’s top middle-market investment bank, is central to how the firm approaches every private credit mandate.

    As private credit continues to expand its footprint in middle-market finance, Post Oak Group is encouraging business owners evaluating growth capital, acquisition financing, or refinancing to consider the full range of alternatives now available to them, and to work with advisors who can help them navigate an increasingly complex capital markets landscape.

    About Post Oak Group

    Post Oak Group is the leading middle-market investment bank headquartered in Houston, Texas. With approximately 300 professionals and more than 250 years of combined leadership experience, the firm has advised on over $82 billion in transactions across 12 countries. Recognized as the top middle-market investment bank in Texas and widely regarded as one of the most connected firms to family offices and venture capital firms globally, Post Oak Group helps clients secure institutional capital through disciplined, strategic execution across the full spectrum of capital markets services, including private credit advisory, private placements, and fund placement services.

    Media Contact

    Organization: Post Oak Group

    Contact Person: David Chua

    Website: https://www.postoakgroup.co/

    Email:
    info@postoakgroup.co

    City: Houston

    State: Texas

    Country:United States

    Release id:48578

    The post Post Oak Group Weighs In on Private Credit’s Expanding Role in Middle-Market Financing appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

    file